Bristol-Myers Promotes Head of Genomics Research to Senior Executive Post | GenomeWeb

NEW YORK, March 12 - Bristol-Myers Squibb has promoted its director of genomics-based pharmaceutical research, Elliot Sigal, to senior vice president in charge of drug discovery and exploratory development, the company said Monday.

The advancement for Sigal represents a "real sign of Elliot's leadership," said BMS spokeswoman Tracy Furey. "He is so highly regarded that he's now leading the whole discovery organization" at BMS' Pharmaceutical Research Institute, she said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.